期刊文献+

胰岛素强化治疗对高血糖严重烧伤患者血清脂联素和C反应蛋白的影响 被引量:6

Effects of intensive insulin therapy on serum adiponectin and C-reactive protein in severely burned patients compli-cated by hyperglycemia
下载PDF
导出
摘要 目的探讨胰岛素强化治疗对高血糖严重烧伤患者血清脂联素和C反应蛋白的影响。方法 40例重度烧伤患者随机分为胰岛素强化治疗组(血糖控制在4.4~6.1mmol/L)和胰岛素常规治疗组(血糖控制在10.0~11.1mmol/L),分别于治疗前和治疗24h、3d、10d抽血测定脂联素和CRP水平。结果胰岛素强化治疗组血清脂联素较治疗前及常规治疗组明显升高(P<0.01),CRP较常规治疗组明显降低(P<0.01)。结论胰岛素强化治疗使血糖控制在4.4~6.1mmol/L,可拮抗烧伤后机体呈现的高炎状态,改善胰岛素抵抗。 Objective To investigate the effects of intensive insulin therapy on serum levels of adiponectin and C-reactive proteinin severely burned patients complicated by hyperglycemia.Methods Forty severely burned patients were randomly divided into intensive insulin therapy group (maintain blood glucose between 4.4~6.1mmol/L) and conventional therapy group(maintain blood glucose between 10.0~11.1mmol/L).ELISA method was used to determine the adiponectin and CRP levels on 24h,3d and 10d after admission.Results Serum levels of CRP in patients received intensive insulin therapy were significantly lower than those who received conventional therapy (P〈0.01),whereas adiponectin levels were significantly higher than conventional group(P〈0.01).Conclusion Intensive insulin therapy to maintain blood glucose between 4.4~6.1mmol/L can alleviate the inflammation response to severe burn and improve insulin resistance.
出处 《中国现代医药杂志》 2010年第10期55-57,共3页 Modern Medicine Journal of China
关键词 高血糖 胰岛素强化治疗 脂联素 C反应蛋白 胰岛素抵抗 Hyperglycemia Intensive insulin therapy Adiponectin C-reactive protein Insulin resistance
  • 相关文献

参考文献8

  • 1Van den Berghe G.Wouters F,et al.Intensive insulin therapy in critically ill patients[J].N Engl J Med,2001,345:1359-1367.
  • 2Hirsch IB,Coviello A,Mazuski J,et al.Intensive insulin therapy in critically ill patients[J].N Engl J Med,2002,346:1586.
  • 3Souba WW.Nutrition support[J].N Engl J Med,1997,336:41.
  • 4Pidcoke HF,Wade CE.Insulin and burned patient[J].Crit Care Med,2007,35(9):s524-530.
  • 5张洁,王方,许海燕,孟雁.炎性因子与胰岛素抵抗[J].世界华人消化杂志,2006,14(32):3121-3125. 被引量:20
  • 6Rey C,Los Arcos M,Concha A,et al.Procalcitonin and C-reactive protein as markers of systemic inflanmmtory response syndrome severity in critically ill children[J].Intensive Care Med,2007,33(3):477-184.
  • 7Ohmura E,Hosaka D,Yazawa M,et al.Association of free fatty acids (FFA)and tumor necrosis factor-α(TNF-α)and insulin-resistance metabolic disorder[J].Horm Metab Res,2007,39(3):212-217.
  • 8Yamauchi T,Kamon J,Minokoshi Y,et al.Adiponectin stimulates glu cose utili-zation and fatty-acid oxidation by activating AMP-acti vated protein kinase[J].Nat Med,2002,8(11):1288-1295.

二级参考文献38

  • 1Cosentino F,Assenza GE.Diabetes and inflammation.Herz 2004, 29:749-759
  • 2Savage DB,Petersen KF,Shulman GI.Mechanisms of insulin resistance in humans and possible links with inflammation.Hypertension 2005, 45:828-833
  • 3Hotamisligil GS.Inflammatory pathways and insulin action.Int J Obes Relat Metab Disord 2003,27 Suppl 3:S53-S55
  • 4Arner P.Insulin resistance in type 2 diabetes --role of the adipokines.Curr Mol Med 2005, 5:333-339
  • 5Stephens JM,Lee J,Pilch PF.Tumor necrosis factor-alpha-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin receptor-mediated signal transduction.J Biol Chem 1997, 272:971-976
  • 6Hotamisligil GS,Peraldi P,Budavari A,Ellis R,White MF,Spiegelman BM.IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha-and obesity-induced insulin resistance.Science 1996, 271:665-668
  • 7Arner P.The adipocyte in insulin resistance:key molecules and the impact of the thiazolidinediones.Trends Endocrinol Metab 2003, 14:137-145
  • 8Gasic S,Tian B,Green A.Tumor necrosis factor alpha stimulates lipolysis in adipocytes by decreasing Gi protein concentrations.J Biol Chem 1999, 274:6770-6775
  • 9Fasshauer M,Klein J,Lossner U,Paschke R.Interleukin (IL)-6 mRNA expression is stimulated by insulin,isoproterenol,tumour necrosis factor alpha,growth hormone,and IL-6 in 3T3-L1adipocytes.Horm Metab Res 2003, 35:147-152
  • 10Kappes A,Loffler G.Influences of ionomycin,dibutyryl-cycloAMP and tumour necrosis factoralpha on intracellular amount and secretion of apM1 in differentiating primary human preadipocytes.Horm Metab Res 2000, 32:548-554

共引文献19

同被引文献57

  • 1蔡玉娥.胰岛素在重度烧伤患者治疗中的应用[J].中原医刊,2007,34(2):44-44. 被引量:1
  • 2van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients[ J ]. N Engl J Med, 2001,345(19) :1 359-1 367.
  • 3Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU [ J ]. N Engl J Med, 2006,354 (5) :449 - 461.
  • 4Arabi YM, Dabbagh OC, Tamim HM, et al. Intensive versus conventional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients [ J ]. Crit Care Med,2008,36(12) :3 190-3 197.
  • 5Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastareh resuscitation in severe sepsis [ J ]. N Engl J Med,2008,358(2) :125 -139.
  • 6De La Rosa Gdel D, Donado JH, Restrepo AH, et al. Strict glycaemic control in patients hospitalised in a mixed medi- cal and surgical intensive care unit:a randomizsed clinical trial[J]. Crit Care,2008,12(5) :R120.
  • 7Griesdale DE, de Souza ILl, van Dam RM, et al. Intensive insulin therapy and mortality among critically ill patients:a meta-analysis including NICE-SUGAR study data [ J ]. CMAJ,2009,180(8) :821 - 827.
  • 8Dellinger R_P, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock:2008 [ J ]. Crit Care Med, 2008,36( 1 ) :296 -327.
  • 9Holm C, H3rbrand F, Mayr M, et al. Acute hyperglycaemia following thermal injury: friend or foe ? [ J ]. Resuscitation, 2004.60( 1 ) ,71 -77.
  • 10]eschke MG,Kulp GA,Kraft R,et al. Intensive insulin therapy in severely burned pediatric patients :a prospective randomized trial[J]. Am J Respir Crit Care Med,2010,182(3) :351 -359.

引证文献6

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部